Analysts from The Economic Times have issued two stock recommendations for Tuesday trading based on technical breakouts and strong price action. According to reports from The Economic Times, both Hindustan Copper and Concord Biotech have broken key resistance levels with strong price action, volume, and bullish momentum, making them attractive for potential investors.
Hindustan Copper has demonstrated a strong breakout above the ₹550 resistance zone with positive price action and rising volume, as reported by The Economic Times. Virat Jagad, Sr Technical Research Analyst at Bonanza Portfolio, notes that the stock is trading above its major EMAs, while RSI remains above 60, indicating improving bullish momentum and supporting further upside potential. The recommendation includes a buying zone of ₹572-575, a stop-loss at ₹515, and a target of ₹655.
Concord Biotech has broken above the ₹1,470 resistance zone with strong price action and improving volume, according to The Economic Times analysis. Similar to Hindustan Copper, the stock is trading above all major EMAs, while RSI remains above 60, indicating sustained bullish momentum and supporting further upside potential. The recommendation includes a buying zone of ₹1,515, a stop-loss at ₹1,440, and a target of ₹1,650.
Concord Biotech has shown strong recent performance with the stock moving up by 4.39% from its previous close of ₹1,451.30, as reported by latest market data. The company has achieved a significant milestone by becoming debt-free for the first time in five years, according to consolidated financials. However, the company witnessed revenue contraction of 11.03% for the first time in three years, with total income declining to ₹270.31 crore in June 2026 from ₹341.43 crore in March 2026. The stock currently trades with a market capitalization of ₹15,849.35 crore and maintains a PE ratio of 55.14.
